In collaboration with the Manke Lab at UMass Dartmouth and the Designer Drug Research Unit at the National Institute on Drug Abuse Intramural Research...
Renowned academic journal praises company for development of psychoplastogens The post Delix gets recognized as leading start-up by Nature Biotechnology...
ATMA Journey Centers Inc. (“ATMA”), an Alberta-based company focused on the international delivery of innovative psychedelic-assisted therapy solutions,...
Tryp Therapeutics, Inc. (CSE: TRYP OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases...
(Salt Lake City) – A fungus that is a common cause of fungal meningitis undergoes a remarkable transformation once it enters the body, allowing it to...
Film screening was followed by audience Q&A session hosted by director The post DOSED 2 screening sells out at Vancouver’s Rio Theatre appeared...
Several academic institutions around the world are heeding the call to quickly build a psychedelics workforce. The post Future Psychedelics Workforce Getting...
From some counties pushing back on access to psilocybin therapy to last minute obstacles to facilitator training programs, Oregon is successfully navigating...
Company claims it will 'disrupt cannabis industry' with its new proprietary technology The post KRTL Biotech to deploy ‘state-of-the-art’ mobile extraction...
The article Algernon Pharmaceuticals Receives Approval for Phase 1 DMT Study was originally published on Microdose. For more on Algernon and their DMT...